Total synthesis of brevenal

Organic Letters

Volumn 11, Issue 12, 2009, Pages 2531-2534

  Takamura, Hiroyoshi ^a   Kikuchi, Shigetoshi ^b   Nakamura, Yuichi ^a   Yamagami, Yuji ^a   Kishi, Takayuki ^a   Kadota, Isao ^a   Yamamoto, Yoshinori ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ETHER DERIVATIVE; THIOBUTABARBITAL; THIOPENTAL;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ETHERS, CYCLIC; MOLECULAR STRUCTURE; STEREOISOMERISM; THIOPENTAL;

EID: 67149128372     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol900769d     Document Type: Article

References (32)

1. (a) Bourdelais, A. J.; Campbell, S.; Jacocks, H.; Naar, J.; Wright, J. L. C.; Carsi, J.; Baden, D. G. Cell. Mol. Neurobiol. 2004, 24, 553-563
2. (b) Bourdelais, A. J.; Jacocks, H. M.; Wright, J. L. C.; Bigwarfe, P. M., Jr.; Baden, D. G. J. Nat. Prod. 2005, 68, 2-6.
3. The antagonistic effect of brevenal on brevetoxin-induced DNA damage is reported, see: Sayer, A.; Hu, Q.; Bourdelais, A. J.; Baden, D. G.; Gibson, J. E. Arch. Toxicol. 2005, 79, 683-688.
4. Abraham, W. M.; Bourdelais, A. J.; Sabater, J. R.; Ahmed, A.; Lee, T. A.; Serebriakov, I.; Baden, D. G. Am. J. Respir. Crit. Care Med 2005, 171, 26-34.
5. (a) Fuwa, H.; Ebine, M.; Sasaki, M. J. Am. Client. Soc. 2006, 28, 9648-9650
6. (b) Fuwa, H.; Ebine, M.; Bourdelais, A. J.; Baden, D. G.; Sasaki, M. J. Am. Chem. Soc. 2006, 128, 16989-16999
7. (c) Ebine, M.; Fuwa, H.; Sasaki, M. Org. Lett. 2008, 10, 2275-2278.
8. Kadota, I.; Ohno, A.; Matsuda, K.; Yamamoto, Y. J. Am. Chem. Soc. 2002, 124, 3562-3566,
9. (a) Nicolaou, K. C.; Nugiel, D. A.; Couladouros, E.; Hwang, C.-K. Tetrahedron 1990, 46, 4517-4552
10. (b) Kadota, I.; Kadowaki, C.; Park, C-H.; Takamura, H.; Sato, K.; Chan, P. W. H.; Thorand, S.; Yamamoto, Y. Tetrahedron 2002, 58, 1799-1816.
11. Racherla, U. S.; Brown, H. C. J. Org. Chem. 1991, 56, 401-404.
12. Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 1989-1993.
13. Marshall, J. A.; Johns, B. A. J. Org. Chem. 1998, 63, 7885-7892,
14. Sasaki and co-workers have reported the same C-C bond formation with this alkyl borate: see ref 4.
15. Nicolaou, K. C.; Prasad, C. V. C.; Hwang, C.-K.; Duggan, M. E.; Veale, C. A. J. Am. Client. Soc. 1989, 111, 5321-5330.
16. (a) Fujiwara, K.; Sato, D.; Watanabe, M.; Morishita, H.; Murai, A.; Kawai, H.; Suzuki, T. Tetrahedron Lett. 2004, 45, 5243-5246
17. (b) Kadota, I.; Abe, T.; Ishitsuka, Y.; Touchy, A. S.; Nagata, R.; Yamamoto, Y. Heterocycles 2007, 74, 617-627.
18. Kadota, I.; Sakaihara, T.; Yamamoto, Y. Tetrahedron Lett. 1996, 37, 3195-3198.
19. Kadota, I.; Takamura, H.; Sato, K.; Ohno, A.; Matsuda, K.; Yamamoto, Y. J. Am. Chem. Soc. 2003, 125, 46-17.
20. For the original conditions, see: (a) Dahanukar, V. H.; Rychnovsky, S. D. J. Org. Chem. 1996, 61, 8317-8320
21. (b) Kopecky, D. J.; Rychnovsky, S. D. J.O rg. Chem. 2000, 65, 191-198
22. (c) Kopecky, D. J.; Rychnovsky, S. D. Org. Synth. 2003, 80, 177-183.
23. None of the other stereoisomers were detected. Although the reaction conditions were optimized, partial decompsition of the substrate 2 was observed in this reaction.
24. (a) Schwab, P.; France, M. B.; Ziller, J. W.; Grabbs, R. H. Angew. Chem., hit. Ed. Engl. 1995, 34, 2039-2041
25. (b) Schwab, P.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1996, 118, 100-110,
26. The reaction of 25 required 3 equiv of 26 for the completion, and the formation of unidentified by-products was observed.
27. For successful examples of the deprotection of TCBn group in similar cases, see ref 12.
28. Sajiki, H.; Kume, A.; Hattori, K.; Hirota, K. Tetrahedron Lett. 2002, 43, 7247-7250.
29. 13C NMR spectra of 28 were identical with those reported previously.
30. (a) Nicolaou, K. C.; Reddy, K. R.; Skokotas, G.; Sato, F.; Xiao, X.-Y. J. Am. Chem. Soc. 1992, 114, 7935-7936
31. (b) Nicolaou, K. C.; Reddy, K. R.; Skokotas, G.; Sato, F.; Xiao, X.-Y.; Hwang, C.-K. J. Am. Chem. Soc. 1993, 115. 3558-3575.
32. For the preparation of the phosphonate 33, see Supporting Information.